Steve Hoffman was a retired businessman when he was asked by Massachusetts Treasurer Deb Goldberg to Chair the Cannabis Control Commission back in 2017. Since his departure from the agency in April of 2022 Hoffman is staying busy and continuing to work with companies in the cannabis industry. It was recently announced that Steve Hoffman has joined the board of Advisors for Biopharmaceutical Research Company. The company based in California is licensed by the DEA to produce cannabis for federally approved research purposes across the United States. This is not the first cannabis project that Hoffman has joined since leaving the Commission. Back in August of 2022 EO Care, a digital health company focused on cannabinoid-based treatments, announced that Hoffman would be joining their team as a board member.
Find the full press release from Biopharmaceutical Research Company on PR Newswire here: https://www.prnewswire.com/news-releases/dea-licensed-pharmaceutical-cannabis-company-biopharmaceutical-research-company-brc-announces-20m-series-a-funding-round-301640321.html
